期刊文献+

霍乱毒素B亚单位-胰岛素原融合蛋白抗糖尿病 被引量:1

Effect of cholera toxoid-proinsulin conjugate and cholera toxin B sub unit admixtures on spontaneous autoimmune diabetes
下载PDF
导出
摘要 目的 观察雌性非肥胖糖尿病(NOD)小鼠口服胰岛素和霍乱毒素B亚单位 胰岛素原融合蛋白(CTB proinsulin) +霍乱毒素B亚单位五聚体(CTB五聚体)对糖尿病发生的影响,为社区非肥胖性糖尿病干预提供参考依据。方法 4 0只雌性3~4周龄NOD小鼠随机分为4组:分别给予磷酸缓冲液(PBS) 5 0 0 μl,胰岛素(insulin) 1mg ,CTB - proinsulin 10 0 μg +CTG五聚体1μg ,CTB - proinsulin 30 0 μg +CTG五聚体3μg。每周灌胃2次至12周龄;从12周龄起,动态监测小鼠尿糖、血糖至2 6周龄,观察糖尿病的发生,比较不同抗原诱导免疫耐受的作用。结果 与PBS组比较,CTB proinsulin +CTG五聚体与胰岛素均能延缓、减少NOD小鼠糖尿病的发生,2 6周龄时小鼠糖尿病的累积发病率:PBS组10 0 % ,CTB proinsulin 10 0 μg +CTG五聚体1μg组、CTG proinsulin 30 0 μg +CTG五聚体3μg组和胰岛素组分别为4 0 % ,4 0 %和5 0 % (P <0 .0 10 )。各组生存时间分布有差别。结论 不同剂量组的CTB proinsulin +CTG五聚体与胰岛素能够提高NOD鼠生存率,并可达到与胰岛素相同保护作用而所需抗原剂量较小。 Objective To observe the diabetes prevention effects of o ral administration of human insulin and admixtures of proinsulin coupled to chol era toxin B subunit(CTB) and CTB (CTB-proinsulin+CTB)on female non-obese diabe tic mice.Methods 40 female NOD mice were divided randomly into fou r groups.Group1:PBS 500μl,group 2:insulin, group 3:CTB-proinsulin100μg+CTB1 ?μg,group 4:CTB-proinsulin300?μg+CTB3?μg.The whole observation lasted 26 months. Glycosuria and glycemia were measured from 11 weeks to 26 weeks. Results Oral administration of insulin and CTB-proinsuli n+CTB to female NOD mice significantly suppressed incidence of diabetes. The cum ulative incidence of PBS,insulin,CTB-proinsulin100?μg+CTB1?μg,CTB-proinsul in300?μg+CTB3?μg were 100%,40%,40%,50% (P<0.010)respectively.Survival distribuding were all significantly difference. Conclusion The needed dose of CTB-proinsulin+CTB is lowe r than that of insulin at the same prevention rate.
出处 《中国公共卫生》 CAS CSCD 北大核心 2005年第5期558-560,共3页 Chinese Journal of Public Health
基金 国家自然科学基金资助 (30 1 70 81 8)
关键词 免疫耐受 胰岛素原 自身免疫性糖尿病 immune tolerance proinsulin autoimmune diabet es
  • 相关文献

参考文献3

二级参考文献14

  • 1[1]Zhang J, Daviadson L, Elisenbarth G, et al. Suppression f diabetic mice by oral administration of porcine insulin[J]. Proc Natl Acad Sci USA, 1991, 88:10252 - 10256.
  • 2[2]Bregenholt S, Wang M, Wolfe T, et al. The cholera toxin B subunit is a numcosal adjuvant for oral tolerance induction in type 1 diabetes [J]. Scand J Immunol, 2003, 57(5) :432 - 438.
  • 3[3]Sadeghi H, Bregenholt S, Wegmann D, et al. Genetic fusion of human insulin B- chain to the B- subunit of cholera toxin enhances in vitro antigen presentation and induction of bystander suppression in vivo [ J ]. Imunology, 2002, 106 (2): 237 - 245.
  • 4[4]Aspord C, Thivolet C. Nasal administration of CTB- insulin induces active tolerance against autoimmune diabetes in non- obese diabetic(NOD) mice[J]. Clin Exp Immunol, 2002, 130(2) :204 - 211.
  • 5[5]Hanninen A. Prevention of Autoimmune Type 1 Diabetes via Mucosal Tolerance: Is Mucosal Autoantigen Administration As Safe and Effective As It Should[J ]. Scand J Immunol, 2000, 52: 217 -225.
  • 6[6]Liu E, Moriyama H, Abiru N, et al. Anti - peptide autoantibodies and fatal anaphylaxis in NOD mice in response to insulin self - peptides B: 9 - 23 and B: 13 - 23 [ J ]. J Clin Invest, 2002, 110 ( 7 ):1021 - 1027.
  • 7Zhang Z J,Proc Natl Acad Sci USA,1991年,88卷,10252页
  • 8Y. Takeda,M. Gotoh,K. Dono,M. Nishihara,T. Grochowiecki,F. Kimura,T. Yoshida,Y. Ohta,H. Ota,H. Ohzato,K. Umeshita,T. Takeda,N. Matsuura,M. Sakon,N. Kayagaki,H. Yagita,K. Okumura,M. Miyasaka,M. Monden.Protection of islet allografts transplanted together with Fas ligand expressing testicular allografts[J]. Diabetologia . 1998 (3)
  • 9Griffith TS,Brunner T,Fletcher SM,et al.Fas ligandinduced apoptosis as a mechanism of immune privilege. Science . 1995
  • 10Tian J,Atkinson MA,Clare-Slazler M,et al.Nasal administration of glutamate decarboxylase (GAD65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes. The Journal of Experimental Medicine . 1996

共引文献2

同被引文献3

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部